(Q42680534)
Statements
1 reference
Pharmacokinetic and tolerability profiles of tobramycin nebuliser solution 300 mg/4 ml administered by PARI eFlow(®) rapid and PARI LC Plus(®) nebulisers in cystic fibrosis patients (English)
1 reference
Mirco Govoni
1 reference
Gianluigi Poli
1 reference
Daniela Acerbi
1 reference
Debora Santoro
1 reference
Helen Cicirello
1 reference
Ottavia Annoni
1 reference
Jozef Ružička
1 reference
8 December 2012
1 reference
1 reference
26
1 reference
2
1 reference
249-255
1 reference
Identifiers
1 reference
1 reference